pharmaphorum March 5, 2024
On the heels of a setback in pharma’s legal attempts to block Medicare’s new medicine price negotiation powers, the US government has said all drugmakers whose products are up for discussion have engaged with the process by filing counteroffers.
US Department of Health and Human Services (HHS) Secretary Xavier Becerra said the milestone showed that the federal government is “committed to constructive dialogue” with the industry through “good-faith, upfront negotiations.”
10 drugs have been selected for the first round of negotiations, which are expected to continue over the next several months and come to a conclusion on 1st August. If an agreement is reached, the new prices will be published on 1st September and come into effect at the start...
Today's Sponsors
Today's Sponsor